Teligent Total Current Liabilities 2010-2021 | TLGT

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Teligent total current liabilities from 2010 to 2021. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.

Teligent Total Current Liabilities 2010-2021 | TLGT

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Teligent total current liabilities from 2010 to 2021. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.

Related Stocks
Company Name	Market Cap
Teva Pharmaceutical Industries (TEVA)	$19B
Dr Reddy's Laboratories (RDY)	$12B
BridgeBio Pharma (BBIO)	$4.3B
Bausch Health Cos (BHC)	$3B
Amphastar Pharmaceuticals (AMPH)	$2.1B
Supernus Pharmaceuticals (SUPN)	$2B
Taysha Gene Therapies (TSHA)	$434M
Personalis (PSNL)	$261M
Assembly Biosciences (ASMB)	$98M
Sol-Gel Technologies (SLGL)	$12M
Evoke Pharma (EVOK)	$7M